ArticleQuantitative imaging in medicine and surgery2025
Functional lung avoidance stereotactic body radiation therapy for central lung cancer patients.
Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: To improve patients' quality of life, it is necessary to preserve the high-functioning regions of the lung. This study aimed to propose a planning strategy that prioritizes sparing ventilation function for stereotactic body radiation therapy (SBRT) in patients with central lung cancer. Methods: Twenty patients with central lung cancer were retrospectively enrolled. Ventilation maps were obtained from 4-dimensional computed tomography by deformable image registration and quantitative analysis. The top 60% and 30-60% of the total lung were defined as high- and medium-ventilation regions, respectively. Clinical plans and functional lung avoidance (FLA) plans were designed for each patient, and FLA plans were optimized to spare high-ventilation (H-V) regions. Dosimetric parameters were compared in terms of tumor coverage, plan heterogeneity, and dose of organs-at-risk (OARs). A patient-specific dose-function response model of Owen was applied to characterize personalized functional damage. Results: FLA plans led to significant reductions in the mean dose of H-V lung than in clinical plans (361.33 Conclusions: FLA plans can preserve the post-radiotherapy lung function, limit the pulmonary toxicity, and further improve life quality for SBRT patients with central lung cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.